Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Authors
Keywords
-
Journal
Science Immunology
Volume 6, Issue 62, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-08-20
DOI
10.1126/sciimmunol.abl4340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
- (2021) Nicolas de Prost et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
- (2021) Paul Bastard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients
- (2021) Rutger Koning et al. INTENSIVE CARE MEDICINE
- Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
- (2021) Sara E. Vazquez et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
- (2021) Jesús Troya et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
- (2021) Paul Bastard et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
- (2021) Paul Bastard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Diverse Functional Autoantibodies in Patients with COVID-19
- (2021) Eric Y. Wang et al. NATURE
- X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
- (2021) Takaki Asano et al. Science Immunology
- Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014
- (2020) Elena Myasoedova et al. ANNALS OF THE RHEUMATIC DISEASES
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
- (2020) Jean-Laurent Casanova et al. CELL
- Type I IFN immunoprofiling in COVID-19 patients
- (2020) Sophie Trouillet-Assant et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
- (2020) Andrew T. Levin et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
- (2020) Lorena Sanchez-Felipe et al. NATURE
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
- Shared and Distinct Functions of Type I and Type III Interferons
- (2019) Helen M. Lazear et al. IMMUNITY
- Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked
- (2018) Jacob M. Rosenberg et al. Frontiers in Immunology
- AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
- (2016) Steffen Meyer et al. CELL
- Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases
- (2016) Sarthak Gupta et al. Arthritis & Rheumatology
- Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency
- (2015) Jolan E. Walter et al. JOURNAL OF CLINICAL INVESTIGATION
- Reproductive and Hormonal Risk Factors for Antinuclear Antibodies (ANA) in a Representative Sample of U.S. Women
- (2014) C. G. Parks et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started